Progress of the diagnosis and treatment of acute leukemia in China: work review of Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences / 白血病·淋巴瘤

Acute leukemia is a kind of malignant proliferative disease originating from hematopoietic stem cells, which is characterized with molecular and clinical heterogeneity. Chemotherapy and hematopoietic stem cell transplantation are the major treatments for acute leukemia. In recent years, the development of targeted therapy has significantly improved the prognosis of acute leukemia patients. This article reviews the part of the work of Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences on the research of pathogenesis, diagnosis and treatment of acute leukemia.

Progress of the diagnosis and treatment of acute leukemia in China: work review of Institute of Hematology&Blood Diseases Hospital, Chinese Academy of Medical Sciences / 白血病·淋巴瘤

Acute leukemia is a kind of malignant proliferative disease originating from hematopoietic stem cells, which is characterized with molecular and clinical heterogeneity. Chemotherapy and hematopoietic stem cell transplantation are the major treatments for acute leukemia. In recent years, the development of targeted therapy has significantly improved the prognosis of acute leukemia patients. This article reviews the part of the work of Institute of Hematology&Blood Diseases Hospital, Chinese Academy of Medical Sciences on the research of pathogenesis, diagnosis and treatment of acute leukemia.